Publication - Consultation paper

Lymphoma clinical quality performance indicators review: consultation

Published: 11 Aug 2017

We are seeking views on lymphoma quality performance indicators (QPIs) following three years of national comparative data.

Lymphoma clinical quality performance indicators review: consultation
7. Survival

7. Survival

Improving survival forms an integral part of the national cancer quality improvement programme. Lymphoma survival analysis will be reported and analysed on a 3 yearly basis by Information Services Division ( ISD). The specific issues which will be addressed will be identified by an expert group ahead of any analysis being undertaken, as per the agreed national cancer quality governance and improvement framework.

The Lymphoma Cancer QPI Group has identified, during the QPI development process, the following issues for survival analysis:

  • 2 and 5 year overall survival

To ensure consistent application of survival analysis, it has been agreed that a single analyst on behalf of all three regional cancer networks undertakes this work. Survival analysis will be scheduled as per the national survival analysis and reporting timetable, agreed with the National Cancer Quality Steering Group and Scottish Cancer Taskforce. This reflects the requirement for record linkage and the more technical requirements of survival analyses which would make it difficult for individual Boards to undertake routinely and in a nationally consistent manner.


Email: Jennifer Doherty,

Phone: 0300 244 4000 – Central Enquiry Unit

The Scottish Government
St Andrew's House
Regent Road